Download our whitepaper,
Prostate Cancer Clinical Trials:
Efficacy Endpoints and Emerging
Therapies
What's Inside:
- Endpoints including PSA response and radiographic progression-free survival.
- Androgen deprivation and next-generation antiandrogen trials.
- Immunotherapy and radioligand therapy integration.
- Trial design considerations for localized vs metastatic disease.
- Patient-reported outcomes and health-related quality of life.
- Long-term safety and cardiovascular risk management.
Access your complimentary whitepaper today:
Prostate Cancer
Prostate cancer is a serious health condition that affects the prostate gland in men, characterized by abnormal cell growth. It can vary in severity and progression, often requiring long-term management and treatment.
Research has significantly progressed from considering prostate cancer solely as a localized condition to understanding its complex mechanisms, which involve genetic, hormonal, and environmental factors.
This advancing knowledge has been essential in developing contemporary therapeutic approaches that aim to manage symptoms, improve overall patient outcomes, and address the multifaceted nature of the disease.
iNGENū’s team of experienced researchers and clinicians specializes in designing and conducting innovative studies. By leveraging enhanced trial design and comprehensive patient-centric strategies, we are committed to accelerating the development of new treatments for prostate cancer.
1 in 8
men will be diagnosed with Prostate Cancer
60%
of cases are in men 65 years or older
Over
1.4mil
new cases were diagnosed globally in 2020
Our clinical team has over
120
years of combined clinical trial experience